Bipartisan Carter Bill to Increase Transparency in Drug Pricing System Approved by Subcommittee
Congressman Earl L. "Buddy" Carter's (R-Ga.) bipartisan legislation to increase transparency in the drug pricing system was approved by the House Energy and Commerce Committee's Health Subcommittee today. Currently, Congress’ independent advisory commissions, the Medicare Payment Advisory Commission (MedPAC) and the Medicaid and CHIP Payment and Access Commission (MACPAC), do not…